N = 56 (%) | |
---|---|
Median Age (years, range) | 68 (42–88) |
Gender | |
Male | 29 (52) |
Female | 27 (48) |
ECOG Performance Status | |
0 | 3 (5) |
1 | 41 (73) |
2 | 12 (21) |
Primary tumor location | |
Head | 28 (50) |
Body | 11 (20) |
Tail | 12 (21) |
Body and tail | 5 (9) |
Stage at start of treatment | |
III | 2 (4) |
IV | 54 (96) |
Metastatic sites | |
Liver | 41 (73) |
Peritoneum | 16 (29) |
Lung | 15 (27) |
Distant lymph nodes | 18 (32) |
Other | 10 (18) |
Number of metastatic sites | |
1 | 29 (52) |
2 | 8 (14) |
3 or more | 16 (29) |
Prior lines of advanced disease therapy | |
0 | 4 (7) |
1 | 20 (36) |
2 | 21 (38) |
3 or more | 11 (20) |